<code id='A6FD4BD52F'></code><style id='A6FD4BD52F'></style>
    • <acronym id='A6FD4BD52F'></acronym>
      <center id='A6FD4BD52F'><center id='A6FD4BD52F'><tfoot id='A6FD4BD52F'></tfoot></center><abbr id='A6FD4BD52F'><dir id='A6FD4BD52F'><tfoot id='A6FD4BD52F'></tfoot><noframes id='A6FD4BD52F'>

    • <optgroup id='A6FD4BD52F'><strike id='A6FD4BD52F'><sup id='A6FD4BD52F'></sup></strike><code id='A6FD4BD52F'></code></optgroup>
        1. <b id='A6FD4BD52F'><label id='A6FD4BD52F'><select id='A6FD4BD52F'><dt id='A6FD4BD52F'><span id='A6FD4BD52F'></span></dt></select></label></b><u id='A6FD4BD52F'></u>
          <i id='A6FD4BD52F'><strike id='A6FD4BD52F'><tt id='A6FD4BD52F'><pre id='A6FD4BD52F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:978
          An illustration of a human torso, through which the intestines, multicolored, are visible.
          Adobe

          We never walk alone. Across the landscape of our bodies, trillions of microbes accompany us on the journey of life, some of them riding it out in the body’s soft bits from first to dying breath.

          A decade or so ago, the human microbiome was a revolutionary concept. Its unknown links to disease intrigued researchers across the globe. Now, some microbiome researchers are trying to usher in a new phase, in which modern tools and analytical approaches can show the connection between microbes and disease, and edge the field closer to potential treatments.

          advertisement

          In the early days of this work, and still today, many findings were about correlations: a certain bug was found in a person with a specific illness. The effort now is to prove causation — which microbes could be directly responsible for the onset or progression of diseases. In the past week alone, three papers published in scientific journals have drawn links between microbiome residents and chronic diseases.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Why failed clinical trials don’t always spell doom for a new drug
          Why failed clinical trials don’t always spell doom for a new drug

          AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Failedtrial,successfuldrug:howanegativereadoutcans

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          GSK to buy asthma

          AdobeLONDON—GSKsaidTuesdayitwouldpurchasetheasthma-focuseddrugdeveloperAiolosBiofor$1billionupfront,